AOD 9604
5mg
⚠️ Not for human consumption. Research purposes only.
Description
AOD 9604 is a modified fragment (amino acids 177-191) of the human growth hormone polypeptide. It has been studied in preclinical and clinical models for its effects on lipid metabolism pathways, specifically lipolysis stimulation and lipogenesis inhibition, without impacting IGF-1 levels or glucose homeostasis.
Key Areas of Study
- Lipolysis pathway research
- lipogenesis inhibition studies
- GH fragment signaling analysis
- adipocyte metabolism modeling
Mechanisms Being Evaluated
AOD 9604 mimics the lipolytic domain of human growth hormone, activating beta-3 adrenergic receptor-mediated fat metabolism pathways. Studies indicate it stimulates lipolysis and inhibits lipogenesis in adipose tissue without affecting carbohydrate metabolism or cell proliferation.
Commonly Researched Uses
Lipid metabolism research, adipocyte signaling studies, growth hormone fragment analysis, beta-3 adrenergic pathway investigations
Recent Studies and Trials
The following peer-reviewed studies and clinical trials have investigated the properties and applications of this peptide:
Anti-Obesity Effects of AOD9604
Published: 2001
Lipolytic and Anti-Lipogenic Properties
Published: 2001
Clinical Safety and Tolerability Study
Published: 2013
Note: These studies are provided for informational and research purposes only. This product is not intended for human consumption.